Leading indicators of community-based violent events among adults with mental illness

Psychological Medicine

Volumn 47, Issue 7, 2017, Pages 1179-1191

  Van Dorn, R A ^a   Grimm, K J ^b   Desmarais, S L ^c   Tueller, S J ^a   Johnson, K L ^a   Swartz, M S ^d  

^a RTI INTERNATIONAL   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoregressive cross lag; longitudinal studies; mental illness; victimization; violence.

Indexed keywords

ADULT; CRIME VICTIM; HOMELESS PERSON; HOSPITALIZATION; HUMAN; MENTAL DISEASE; META ANALYSIS; STATISTICS AND NUMERICAL DATA; VIOLENCE;

ADULT; CRIME VICTIMS; HOMELESS PERSONS; HOSPITALIZATION; HUMANS; MENTAL DISORDERS; VIOLENCE;

EID: 85006817393     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291716003160     Document Type: Article

References (52)

1. Citrome L, Volavka J (1997). Psychopharmacology of violence: Part II: beyond the acute episode. Psychiatric Annals 27, 696-703.
2. Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer J-P, McEvoy J, Cooper TB, Chakos M, Lieberman JA (2001). Effects of clozapine, olanzapine, risperidone, haloperidol on hostility among patients with schizophrenia. Psychiatric Services 52, 1510-1514.
3. Coid JW, Kallis C, Doyle M, Shaw J, Ullrich S (2015). Identifying causal risk factors for violence among discharged patients. PLOS ONE 10, e0142493.
4. Curran PJ, Hussong AM (2009). Integrative data analysis: the simultaneous analysis of multiple data sets. Psychological Methods 14, 81-100.
5. Cuthbert BN, Insel TR (2010). Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophrenia Bulletin 36, 1061-1062.
6. Dack C, Ross J, Papadopoulos C, Stewart D, Bowers L (2013). A review and metaanalysis of the patient factors associated with psychiatric inpatient aggression. Acta Psychiatrica Scandinavica 127, 255-268.
7. Denson TF (2015). Four promising psychological interventions for reducing reactive aggression. Current Opinion in Behavioral Sciences 3, 136-141.
8. Desmarais SL, Van Dorn RA, Johnson KL, Grimm KJ, Douglas KS, Swartz MS (2014). Community violence perpetration and victimization among adults with mental illnesses. American Journal of Public Health 104, 2342-2349.
9. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS (1990). Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16, 57-67.
10. Fazel S, Långström N, Hjern A, Grann M, Lichtenstein P (2009). Schizophrenia, substance abuse, violent crime. JAMA 301, 2016-2023.
11. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for Axes I and II DSM-IV Disorders-Patient Edition (SCID-I/P). Biometrics Research Department, New York State Psychiatric Institute: New York.
12. Glass GV (1976). Primary, secondary, meta-analysis. Educational Researcher 5, 3-8.
13. Glickman ME, Rao SR, Schultz MR (2014). False discovery rate control is a recommended alternative to Bonferronitype adjustments in health studies. Journal of Clinical Epidemiology 67, 850-857.
14. Goldman-Rakic PS (1994). Working memory dysfunction in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences 6, 348-357.
15. Grimm KJ, Ram N (2009). Nonlinear growth models in M plus and SAS. Structural Equation Modeling 16, 676-701.
16. Grubaugh AL, Zinzow HM, Paul L, Egede LE, Frueh BC (2011). Trauma exposure and posttraumatic stress disorder in adults with severe mental illness: a critical review. Clinical Psychology Review 31, 883-899.
17. Kay SR, Flszbein A, Opfer LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
18. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ (1997). Coming to terms with the terms of risk. Archives of General Psychiatry 54, 337-343.
19. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209-1223.
20. Lindenmayer J-P, Liu-Seifert H, Kulkarni PM, Kinon BJ, Stauffer V, Edwards SE, Chen L, Adams DH, Ascher-Svanum H, Buckley PF (2009). Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. Journal of Clinical Psychiatry 70, 990-996.
21. Mayfield D, McLeod G, Hall P (1974). The CAGE questionnaire: validation of a new alcoholism screening instrument. American Journal of Psychiatry 131, 1121-1123.
22. McArdle JJ (1994). Structural factor analysis experiments with incomplete data. Multivariate Behavioral Research 29, 409-454.
23. Michie C, Cooke DJ (2006). The structure of violent behavior a hierarchical model. Criminal Justice and Behavior 33, 706-737.
24. Moberg T, Nordström P, Forslund K, Kristiansson M, Åsberg M, Jokinen J (2011). CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. Journal of Affective Disorders 132, 173-178.
25. Monahan J, Redlich AD, Swanson J, Robbins PC, Appelbaum PS, Petrila J, Steadman HJ, Swartz M, Angell B, McNiel DE (2005). Use of leverage to improve adherence to psychiatric treatment in the community. Psychiatric Services 56, 37-44.
26. Nestor PG (2014). Mental disorder and violence: personality dimensions and clinical features. American Journal of Psychiatry 159, 1973-1978.
27. Nolan KA, Volavka J, Czobor P, Sheitman B, Lindenmayer J-P, Citrome LL, McEvoy J, Lieberman JA (2005). Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder. Journal of Psychiatric Research 39, 109-115.
28. Odgers CL, Mulvey EP, Skeem JL, Gardner W, Lidz CW, Schubert C (2009). Capturing the ebb and flow of psychiatric symptoms with dynamical systems models. American Journal of Psychiatry 166, 575-582.
29. Overall JE (1974). The Brief Psychiatric Rating Scale in psychopharmacology research. In Psychological Measurements in Psychopharmacology (ed. R Olivier-Martin), pp. 67-78. Karger: Oxford.
30. Oxman AD, Clarke MJ, Stewart LA (1995). From science to practice: meta-analyses using individual patient data are needed. JAMA 274, 845-846.
31. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996). A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 49, 1373-1379.
32. Pescosolido BA, Monahan J, Link BG, Stueve A, Kikuzawa S (1999). The public's view of the competence, dangerousness, need for legal coercion of persons with mental health problems. American Journal of Public Health 89, 1339-1345.
33. Rhemtulla M, Brosseau-Liard PE, Savalei V (2012). When can categorical variables be treated as continuous A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions. Psychological Methods 17, 354-373.
34. Scheller-Gilkey G, Moynes K, Cooper I, Kant C, Miller AH (2004). Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophrenia Research 69, 167-174.
35. Silver E, Piquero AR, Jennings WG, Piquero NL, Leiber M (2011). Assessing the violent offending and violent victimization overlap among discharged psychiatric patients. Law and Human Behavior 35, 49-59.
36. Singh MM, Kay SR (1975). A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologia 43, 103-113.
37. Skeem JL, Schubert C, Odgers C, Mulvey EP, Gardner W, Lidz C (2006). Psychiatric symptoms and community violence among high-risk patients: a test of the relationship at the weekly level. Journal of Consulting and Clinical Psychology 74, 967-979.
38. Smith ML, Glass GV (1977). Meta-analysis of psychotherapy outcome studies. American Psychologist 32, 752-760.
39. Steadman HJ, Mulvey EP, Monahan J, Robbins PC, Appelbaum PS, Grisso T, Roth LH, Silver E (1998). Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives of General Psychiatry 55, 393-401.
40. Swanson J, Swartz M, Elbogen E, Van Dorn R, Ferron J, Wagner H, McCauley B, Kim M (2006a). Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness. American Journal of Psychiatry 163, 1943-1951.
41. Swanson JW, Swartz MS, Elbogen EB (2004). Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in communitybased treatment. Schizophrenia Bulletin 30, 3-20.
42. Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup TS, McEvoy JP, Lieberman JA (2006b). A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry 63, 490-499.
43. Swanson JW, Swartz MS, Van Dorn RA, Volavka J, Monahan J, Stroup TS, McEvoy JP, Wagner HR, Elbogen EB, Lieberman JA (2008). Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. British Journal of Psychiatry 193, 37-43.
44. Tueller SJ, Johnson KL, Grimm KJ, Desmarais SL, Sellers BG, Van Dorn RA (2016). Effects of sample size and distributional assumptions on competing models of the factor structure of the PANSS and BPRS. International Journal of Methods in Psychiatric Research. Published online 2 December 2016. doi:10. 1002/mpr. 1549.
45. Van Dorn R, Volavka J, Johnson N (2012). Mental disorder and violence: is there a relationship beyond substance use Social Psychiatry and Psychiatric Epidemiology 47, 487-503.
46. Van Dorn RA, Desmarais SL, Grimm KJ, Tueller SJ, Johnson KL, Sellers BG, Swartz MS (2016). The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS. Psychiatry Research 245, 83-90.
47. Virkkunen M, Linnoila M (1990). Serotonin in early onset, male alcoholics with violent behaviour. Annals of Medicine 22, 327-331.
48. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry 44, 241-247.
49. Volavka J (1999). The neurobiology of violence: an update. Journal of Neuropsychiatry and Clinical Neurosciences 11, 307-314.
50. Volavka J (2008). Neurobiology of Violence. American Psychiatric Publishing, Inc. : Washington, DC.
51. Volavka J, Czobor P, Citrome L, Van Dorn RA (2014). Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. CNS Spectrums 19, 374-381.
52. Witt K, Van Dorn R, Fazel S (2013). Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies. PLOS ONE 8, e55942.